 |
FILE PHOTO: A CVS Pharmacy in the United States, as CVS Health agrees to a $315 million settlement over alleged unlawful opioid prescriptions.
CVS to Pay $315 Million to Settle US Opioid Prescription Case
WASHINGTON — October 14, 2026
CVS Health has agreed to pay $315 million to settle US Justice Department allegations that the pharmacy chain unlawfully filled prescriptions for addictive opioid painkillers without a legitimate medical need. The agreement also requires the company to strengthen its procedures for identifying and reporting potentially illegal drug dispensing.
The settlement resolves a lawsuit announced by the Justice Department in 2024. The case alleged that CVS violated the federal Controlled Substances Act by filling opioid and other narcotic prescriptions unlawfully, then improperly seeking payments from federal healthcare programs, including Medicare, in violation of the False Claims Act.
Under a separate agreement with the Drug Enforcement Administration, CVS will establish procedures to monitor potentially unlawful dispensing at its pharmacies, receive reports of suspicious activity and evaluate doctors suspected of illegally prescribing opioids.
The Justice Department said the settlement was part of its efforts to address the US opioid epidemic by holding pharmacies accountable for allegedly dispensing controlled substances unlawfully. The lawsuit was filed in federal court in Rhode Island and originated from a whistleblower complaint brought by a former CVS employee.
CVS denied the allegations and said it was not admitting wrongdoing as part of the settlement. The company said its more than 27,000 pharmacists were trained to support the safe and appropriate use of medications.
The lawsuit alleged that CVS filled prescriptions for excessive quantities of opioids and other drugs, including prescriptions from doctors operating so-called pill mills. These are medical practices accused of issuing large amounts of addictive painkillers without legitimate medical purposes.
According to the lawsuit, CVS was among the largest opioid dispensers in the country, selling more than 12 billion doses of the drugs between 2015 and 2020. The allegations formed part of a broader effort by US authorities to address the role of drug manufacturers, distributors and pharmacies in the national addiction crisis.
The settlement follows other legal agreements involving pharmacy chains. In August, Walmart agreed to pay $50 million to resolve a separate Justice Department lawsuit over allegations that it unlawfully dispensed opioid prescriptions. Walmart did not face the same settlement terms as CVS in the cases described by the source.
CVS had also agreed in 2022 to pay nearly $5 billion to resolve thousands of claims brought by state and local governments and Native American tribal governments. Those cases were part of wider legal action against companies accused of contributing to the opioid epidemic.
The latest agreement adds financial penalties and new monitoring obligations to CVS’s existing legal history involving opioid dispensing. Although the company has agreed to settle the federal case, it has not admitted wrongdoing, and the allegations in the lawsuit should not be treated as findings of guilt.
